Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.

Serological diagnostics in myasthenia gravis based on novel assays and recently identified antigens.

Zisimopoulou P, Brenner T, Trakas N, Tzartos SJ.

Autoimmun Rev. 2013 Jul;12(9):924-30. doi: 10.1016/j.autrev.2013.03.002. Epub 2013 Mar 26. Review.

PMID:
23537507
2.

Titin antibodies in "seronegative" myasthenia gravis--A new role for an old antigen.

Stergiou C, Lazaridis K, Zouvelou V, Tzartos J, Mantegazza R, Antozzi C, Andreetta F, Evoli A, Deymeer F, Saruhan-Direskeneli G, Durmus H, Brenner T, Vaknin A, Berrih-Aknin S, Behin A, Sharshar T, De Baets M, Losen M, Martinez-Martinez P, Kleopa KA, Zamba-Papanicolaou E, Kyriakides T, Kostera-Pruszczyk A, Szczudlik P, Szyluk B, Lavrnic D, Basta I, Peric S, Tallaksen C, Maniaol A, Gilhus NE, Casasnovas Pons C, Pitha J, Jakubíkova M, Hanisch F, Bogomolovas J, Labeit D, Labeit S, Tzartos SJ.

J Neuroimmunol. 2016 Mar 15;292:108-15. doi: 10.1016/j.jneuroim.2016.01.018. Epub 2016 Jan 27.

PMID:
26943968
3.

Thymus histology and concomitant autoimmune diseases in Japanese patients with muscle-specific receptor tyrosine kinase-antibody-positive myasthenia gravis.

Nakata R, Motomura M, Masuda T, Shiraishi H, Tokuda M, Fukuda T, Ando T, Yoshimura T, Tsujihata M, Kawakami A.

Eur J Neurol. 2013 Sep;20(9):1272-6. doi: 10.1111/ene.12169. Epub 2013 May 17.

PMID:
23679930
4.

MuSK antibodies in AChR Ab-seropositive MG vs AChR Ab-seronegative MG.

Ohta K, Shigemoto K, Kubo S, Maruyama N, Abe Y, Ueda N, Ohta M.

Neurology. 2004 Jun 8;62(11):2132-3. No abstract available.

PMID:
15184636
5.

Development of a highly sensitive diagnostic assay for muscle-specific tyrosine kinase (MuSK) autoantibodies in myasthenia gravis.

Trakas N, Zisimopoulou P, Tzartos SJ.

J Neuroimmunol. 2011 Dec 15;240-241:79-86. doi: 10.1016/j.jneuroim.2011.09.007. Epub 2011 Oct 10.

PMID:
21993075
6.

The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies.

Romi F, Skeie GO, Aarli JA, Gilhus NE.

Arch Neurol. 2000 Nov;57(11):1596-600.

PMID:
11074791
7.

[Autoantibodies detected in acetylcholine receptor antibody-negative myasthenia gravis].

Ohta R, Motomura M.

Rinsho Byori. 2014 Mar;62(3):255-60. Review. Japanese.

PMID:
24800501
8.

[Seronegative myasthenia gravis].

Gajdos P.

Rev Neurol (Paris). 2004 Feb;160(2):159-62. Review. French.

PMID:
15034472
9.

Prevalence of myasthenia gravis and associated autoantibodies in paraneoplastic pemphigus and their correlations with symptoms and prognosis.

Wang R, Li J, Wang M, Hao H, Chen X, Li R, Zhu X.

Br J Dermatol. 2015 Apr;172(4):968-75. doi: 10.1111/bjd.13525. Epub 2015 Mar 5.

PMID:
25388377
10.

Diagnostic use of autoantibodies in myasthenia gravis.

Leite MI, Waters P, Vincent A.

Autoimmunity. 2010 Aug;43(5-6):371-9. doi: 10.3109/08916930903541208. Review.

PMID:
20380582
11.

Non-radioactive serological diagnosis of myasthenia gravis and clinical features of patients from Tianjin, China.

Yang L, Maxwell S, Leite MI, Waters P, Clover L, Fan X, Zhang D, Yang C, Beeson D, Vincent A.

J Neurol Sci. 2011 Feb 15;301(1-2):71-6. doi: 10.1016/j.jns.2010.10.023. Epub 2010 Dec 4.

PMID:
21131008
12.

[Autoantibodies in myasthenia gravis].

Motomura M, Narita Masuda T.

Brain Nerve. 2013 Apr;65(4):433-9. Review. Japanese.

PMID:
23568991
13.

Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis.

Pevzner A, Schoser B, Peters K, Cosma NC, Karakatsani A, Schalke B, Melms A, Kröger S.

J Neurol. 2012 Mar;259(3):427-35. doi: 10.1007/s00415-011-6194-7. Epub 2011 Aug 5.

PMID:
21814823
14.

Titin and ryanodine receptor autoantibodies in dogs with thymoma and late-onset myasthenia gravis.

Shelton GD, Skeie GO, Kass PH, Aarli JA.

Vet Immunol Immunopathol. 2001 Jan 10;78(1):97-105.

PMID:
11182151
15.

[Myasthenia gravis induced by autoantibodies against MuSK].

Shigemoto K, Konishi T, Ohta M.

Nihon Rinsho. 2008 Jun;66(6):1149-54. Review. Japanese.

PMID:
18540361
16.

Seronegative myasthenia gravis.

Vincent A, McConville J, Farrugia ME, Newsom-Davis J.

Semin Neurol. 2004 Mar;24(1):125-33. Review.

PMID:
15229799
17.

Diagnostic and clinical classification of autoimmune myasthenia gravis.

Berrih-Aknin S, Frenkian-Cuvelier M, Eymard B.

J Autoimmun. 2014 Feb-Mar;48-49:143-8. doi: 10.1016/j.jaut.2014.01.003. Epub 2014 Feb 13. Review.

PMID:
24530233
18.

Muscle autoantibodies in myasthenia gravis: beyond diagnosis?

Meriggioli MN, Sanders DB.

Expert Rev Clin Immunol. 2012 Jul;8(5):427-38. doi: 10.1586/eci.12.34. Review.

19.

[Clinical features of myasthenia related with autoantibodies to muscle specific tyrosine kinase (MuSK)].

Sanadze AG, Sidnev DV, Karganov MIu.

Zh Nevrol Psikhiatr Im S S Korsakova. 2010;110(12):72-6. Russian.

PMID:
21311492
20.

Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction.

Gomez AM, Van Den Broeck J, Vrolix K, Janssen SP, Lemmens MA, Van Der Esch E, Duimel H, Frederik P, Molenaar PC, Martínez-Martínez P, De Baets MH, Losen M.

Autoimmunity. 2010 Aug;43(5-6):353-70. doi: 10.3109/08916930903555943. Review.

PMID:
20380584

Supplemental Content

Support Center